Techniques for characterising long COVID in real world data

Techniques for characterising long COVID in real world data

Dettagli Bibliografici
Autori principali:	Kostka, K, Minty, E, Prieto-Alhambra, D, Delmestri, A, Jödicke, A, Omondi, B
Natura:	Conference item
Lingua:	English
Pubblicazione:	Wiley 2022

Documenti analoghi

Curator – a data curation tool for clinical real-world evidence
di: Delmestri, A, et al.
Pubblicazione: (2023)

Curator – A data curation tool for clinical real-world evidence
di: Antonella Delmestri, et al.
Pubblicazione: (2023-01-01)

The burden of long COVID: a multinational cohort analysis of Spanish and UK data including SARS-CoV-2 infections, reinfections, and matched contemporaneous test negative controls
di: Prieto Alhambra, D, et al.
Pubblicazione: (2023)

Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
di: Elhussein, L, et al.
Pubblicazione: (2023)

Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data
di: Leena Elhussein, et al.
Pubblicazione: (2023-01-01)

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis
di: Yuchen Guo, et al.
Pubblicazione: (2024-10-01)

Machine learning methods for propensity and disease risk score estimation in high-dimensional data: a plasmode simulation and real-world data cohort analysis
di: Guo, Y, et al.
Pubblicazione: (2024)

Characterising anti-osteoporosis drug users in real world primary care settings in Spain: A data-driven cluster analysis
di: Khalid, S, et al.
Pubblicazione: (2017)

Three strategies to measure frailty and/or complex health needs in real world data: An analysis of UK primary care and hospital linked data
di: Elhussein, L, et al.
Pubblicazione: (2020)

Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom
di: Jödicke, AM, et al.
Pubblicazione: (2023)

Fracture risk following the initiation of antihypertensive therapy amongst frail elderly people: a self-controlled case series analysis
di: Jödicke, AM, et al.
Pubblicazione: (2021)

Risk of falls following the initiation of antihypertensives in the elderly: a self-controlled case series in the UK
di: Jödicke, AM, et al.
Pubblicazione: (2021)

Prevalence and mortality of individuals with X-linked hypophosphataemia: a United Kingdom real world data analysis
di: Hawley, S, et al.
Pubblicazione: (2019)

The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis
di: Kostka, K, et al.
Pubblicazione: (2023)

Effect of COVID-19 vaccines on post-COVID cardiac and thromboembolic complications
di: Mercadé Besora, N, et al.
Pubblicazione: (2023)

Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation
di: Català, M, et al.
Pubblicazione: (2023)

Bisphosphonate use and risk of severe acute kidney injury: a self-controlled case series in frail elderly patients in the UK
di: Oda, T, et al.
Pubblicazione: (2021)

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data
di: Khalid, S, et al.
Pubblicazione: (2021)

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study
di: Markus, AF, et al.
Pubblicazione: (2023)

The burden of post-acute COVID-19 symptoms in a multinational network cohort analysis
di: Kristin Kostka, et al.
Pubblicazione: (2023-11-01)

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
di: Barclay, NL, et al.
Pubblicazione: (2024)

Characterising the treatment of thromboembolic events after COVID-19 vaccination in 4 European countries and the US: An international network cohort study
di: Aniek F. Markus, et al.
Pubblicazione: (2023-03-01)

HLA alleles, COVID-19 vaccine antibody response and real-world breakthrough outcomes
di: Xie, J, et al.
Pubblicazione: (2023)

Estimating the incidence and key risk factors of cardiovascular disease in patients at high risk of imminent fracture using routinely collected real-world data from the UK
di: Pineda-Moncusí, M, et al.
Pubblicazione: (2022)

Venous or arterial thrombosis and mortality among COVID-19 cases: a European network cohort study
di: Burn, E, et al.
Pubblicazione: (2022)

CPRD GOLD and linked ONS mortality records: Reconciling guidelines
di: Delmestri, A, et al.
Pubblicazione: (2019)

Data-driven cluster analysis for identifying groups within users of anti-osteoporosis medication, using real-world primary care data.
di: Khalid, S, et al.
Pubblicazione: (2017)

The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
di: Barclay, NL, et al.
Pubblicazione: (2024)

The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study
di: Nicola L. Barclay, et al.
Pubblicazione: (2024-03-01)

Characterisation of a Real-World Søderberg Electrode
di: Ralph Ivor Glastonbury, et al.
Pubblicazione: (2020-12-01)

Sub-groups of anti-osteoporosis drug users, and associated fracture risk in real world primary care settings: a data-driven cluster analysis
di: Khalid, S, et al.
Pubblicazione: (2017)

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study
di: Nicola L. Barclay, et al.
Pubblicazione: (2024-06-01)

Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data
di: Platzbecker K, et al.
Pubblicazione: (2022-11-01)

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
di: Li, X, et al.
Pubblicazione: (2021)

Development of the ECHOES national dataset: a resource for monitoring post-acute and long-term COVID-19 health outcomes in England
di: Hester Allen, et al.
Pubblicazione: (2025-03-01)

Knee and hip osteoarthritis and risk of nine cancers in a large real-world matched cohort study
di: Turkiewicz, A, et al.
Pubblicazione: (2021)

The performance of instrumental variables in medical device epidemiology: A simulation study of non-normally distributed continuous outcome data based on real world post-operative PROMs
di: Prats-Uribe, A, et al.
Pubblicazione: (2020)

An open algorithm to pre-process free text self-reported medications data in UK biobank
di: Xie, J, et al.
Pubblicazione: (2022)

Treatment patterns for osteoporosis medications in five European countries: a multinational real world cohort analysis
di: Robinson, DE, et al.
Pubblicazione: (2022)

Negative control time window to identify residual confounding in comparative effectiveness study: An example of bisphosphonate use and risk of fracture
di: Robinson, D, et al.
Pubblicazione: (2018)